Here are relevant reports on : rapid-dna-analysis-market
-
Wine Testing Market by Type (Chemical, Microbial, Sensory Analysis, Contaminant), Technology (Manual/Wet Chemistry, Spectroscopy, Chromatography, Rapid Detection Kits, AI & Machine Learning), End-User, and Region - Global Forecast to 2030
The wine testing market is projected to expand from USD XX million in 2025 to USD XX million by 2030, at a CAGR of XX% during the forecast period. The report profiles key players such as ETS Laboratories (US), Enartis USA (US), Brewing and Distilling Analytical Services - BDAS (US), WineChek (US), bioMérieux (France), Agilent (US), Hanna Instruments (US), LabLynx (US), SGS (Switzerland), Eurofins (Luxembourg), TÜV SÜD (Germany), ALS Limited (Australia), Bureau Veritas S.A. France, Intertek Group plc (UK), Romer Labs Division Holding GmbH (Austria).
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Europe Nucleic Acid Isolation and Purification Market by Product (Kits, Reagents, Instruments), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA, mRNA), Application (Diagnostics, Personalized Medicine), End User (CROs) - Forecast to 2030
Europe Nucleic Acid Isolation and Purification Market
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Nucleic Acid Isolation and Purification Market by Product (Kits, Reagents, Instruments), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA), Application (Diagnostics, Personalized Medicine), & End User (CROs) - Forecast to 2030
Asia Pacific Nucleic Acid Isolation and Purification Market
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
North America Nucleic Acid Isolation and Purification Market by Product (Kits, Reagents, Instruments), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA), Application (Diagnostics, Personalized Medicine), End User (CROs) - Forecast to 2030
The North America Nucleic Acid Isolation and Purification Market, valued at US$2.80 billion in 2024, stood at US$2.98 billion in 2025 and is projected to advance at a resilient CAGR of 9.3% from 2025 to 2030, culminating in a forecasted valuation of US$4.64 billion by the end of the period. The growth of the North America nucleic acid isolation and purification market is largely dependent on the region's substantial number of molecular tests and quick acceptance of NGS-based workflows.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Viral Vector & Plasmid DNA Manufacturing Market by Type (Viral Vector (Retroviruses, Adenoviruses, AAV, Lentiviruses), Plasmid DNA), Workflow (Upstream, Downstream), Application (Cell & Gene Therapy), Diseases (Cancer), End User - Global Forecast to 2028
The global viral vector manufacturing market, valued at US$4.8 billion in 2022, stood at US$5.5 billion in 2023 and is projected to advance at a resilient CAGR of 18.2% from 2023 to 2028, culminating in a forecasted valuation of US$12.8 billion by the end of the period. The growth of this market is majorly driven by g rising prevalence of target diseases and disorders, the availability of funding for gene therapy development, and effectiveness of viral vectors in gene therapy delivery.
- Published: June 2023
- Price: $ 4950
- TOC Available:
-
DNA Sequencing Market - Global Forecast to 2030
The DNA sequencing market has experienced significant growth and transformation in recent years, driven by advancements in sequencing technologies, decreasing costs, and expanding applications. Here is an overview of the market outlook for DNA sequencing:
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Global DNA and Gene Chip (Microarrays) Market (2010 – 2015)
The Global DNA & Gene Chip (microarray) market was valued at $760 million in 2010 and is expected to reach $1,425.2 million by 2015 growing at a CAGR of and 13.4%. The oDNA segment accounted for the largest share – 98% – of the global DNA & gene chip market in 2010.
- Published: May 2011
- Price: $ 4950
- TOC Available:
-
Polymerase Chain Reaction Market – Usage Pattern and Replacement Trends, End User Analysis, Pricing Analysis, Comparative Analysis, Competitive Landscape Comparative Analysis and End User Preference Study
Polymerase chain reaction (PCR) is one of the revolutionary life science technologies that has not only made tremendous impact on the scientific community, but also affected many aspects of diseases diagnosis and treatment. The overall market for Polymerase chain reaction (PCR) technology has observed steady growth due to the expansion in its application areas and increased accuracy and precision. Specific technology segments of the PCR market, such as dPCR (digital PCR) and qPCR (real-time PCR), are witnessing higher market growth owing to their benefits such as real-time process monitoring, low reagent consumption, automation of workflow, and greater reproducibility and precision.
- Published: March 2016
- Price: $ 4950
- TOC Available:
-
Rapid Liquid Printing Market by Offering (Printers, Services, Materials, Software), Application (Prototyping, Functional Part/End-Use Manufacturing, Tooling), Vertical (Consumer Products, Fashion), and Region - Global Forecast to 2027
The Rapid Liquid Printing Market is expected to grow from USD 48 million in 2023 to USD 284 million by 2027, at a CAGR of 55.6% during the forecast period. Major players involved in the rapid liquid printing market include Steelcase (US), Stratasys (US), 3D Systems (US), Materilise (Belgium), ExOne (US), EOS (Germany), Dassault Systemes (France), Autodesk (US), Native Canada Footwear (Canada), and BMW (Germany).
- Published: August 2020
- Price: $ 4950
- TOC Available:
-
Europe Epigenetics Market by Product & Service [Enzymes, Kits & Reagents (Antibodies), Software], Method [DNA Methylation, Histone Modification], Technique [NGS, PCR], Application [Oncology, Immunology, Developmental Biology], End User - Forecast to 2030
The Europe epigenetics market, valued at US$0.57 billion in 2024, stood at US$0.63 billion in 2025 and is projected to advance at a resilient CAGR of 14.1% from 2025 to 2030, culminating in a forecasted valuation of US$1.22 billion by the end of the period. Growth is supported by a well-funded life sciences ecosystem, with rising oncology and precision medicine programs that increasingly rely on DNA methylation and chromatin profiling for biomarker discovery and translational research.
- Published: January 2026
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
